Hyperprolactinemia Clinical Trial
Official title:
Hyperprolactinemia and Adrenal Steroidogenesis: is There a Link?
The purpose of this study is to explore the effects of prolactin on adrenal steroid profiles in patients with hyperprolactinemia due to prolactinomas before and after initialisation of treatment.
Prolactin is known to influence many biological processes. One potential target is the adrenal gland, where prolactin may stimulate the production of adrenal steroid hormones. Conditions of increased prolactin production(hyperprolactinemia) could, therefore, increase concentrations of adrenal steroids. One of the potential implications would be false doping accusations of athletes engaging in elite sports. This interaction between prolactin and adrenal steroidogenesis, however, remains poorly understood, and the available research findings are conflicting. The investigators, therefore, seek to explore the relationship between prolactin and adrenal steroidogenesis by monitoring prolactin levels and blood and urinary steroid profiles of patients with hyperprolactinemia due to prolactinomas before and after treatment initialisation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03569787 -
Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
|
||
| Completed |
NCT02098668 -
Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
|
N/A | |
| Completed |
NCT03038308 -
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT00541554 -
Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
|
Phase 4 | |
| Completed |
NCT01270711 -
Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)
|
N/A | |
| Completed |
NCT02956447 -
Administration of Kisspeptin in Patients With Hyperprolactinemia
|
Phase 2 | |
| Recruiting |
NCT05033119 -
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
|
||
| Completed |
NCT06326840 -
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
|
N/A | |
| Withdrawn |
NCT00699530 -
Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
|
N/A | |
| Not yet recruiting |
NCT00315081 -
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
|
Phase 3 | |
| Recruiting |
NCT04746313 -
Prevalence of Hyperprolactinemia in Systemic Scleroderma
|
||
| Recruiting |
NCT00914823 -
Kisspeptin Administration in the Adult
|
Phase 1 | |
| Suspended |
NCT02603549 -
Pituitary Function and Spontaneous Intracranial Hypotension
|
||
| Completed |
NCT01852331 -
Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
|
Phase 2 | |
| Completed |
NCT01338298 -
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
|
N/A | |
| Completed |
NCT01052948 -
The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events
|
N/A | |
| Completed |
NCT00436111 -
Characterization of Macroprolactinemia
|
N/A | |
| Active, not recruiting |
NCT04439747 -
Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease
|
||
| Recruiting |
NCT01742390 -
A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
|
Phase 4 | |
| Completed |
NCT00625950 -
Endometriosis Patients Undergoing Quinagolide Treatment
|
Phase 4 |